{ "items": [ "\n\n
\n \n 14 July 2016\n \n
\n\n \n \n \n\n \n \n \nThree Ludwig Oxford group leaders have been successful in the 2016 University of Oxford Recognition of Distinction exercise.
\n \n\n\n \n 8 July 2016\n \n
\n\n \n\n \n\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Target Discovery Institute is opening its doors on Saturday 10th September 2016, 10am-4pm.
\n \n\n\n \n 5 July 2016\n \n
\n\n \n\n \n\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nA team of Ludwig post-docs and students spent a day in a busy Oxford shopping centre - giving shoppers an interactive introduction to cancer biology and research.
\n \n\n\n \n 22 June 2016\n \n
\n\n \n\n \n\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nSaturday 2nd July, Templars Square Shopping Centre, Oxford.
\n \n\n\n \n 12 May 2016\n \n
\n\n \n\n \n\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nJoin Ludwig Clinical Fellow Mike White to learn about the latest cancer research, in the pub. The event is part of the successful Pint of Science festival.
\n \n\n\n \n 7 May 2016\n \n
\n\n \n \n \n\n \n \n \nWe are pleased to welcome a new group leader to Ludwig Oxford: Dr. Chunxiao Song. Chunxiao has joined us as a Ludwig Assistant Member and his group will be based in the Target Discovery Institute. His research focus is chemical epigenetics. He joins us from Stanford University, where he was a post-doctoral researcher in Stephen Quake's group.
\n \n\n\n \n 7 May 2016\n \n
\n\n \n \n \n\n \n \n \nA study by Benjamin Schuster-Boeckler, Skirmantas Kriaucionis and colleagues at Ludwig Oxford gives new twist on how chemical modifications on DNA alter the rate of mutations. Their work \u2013 now published in eLife \u2013 investigated the effect of the epigenetically modified DNA base 5-hydroxymethylcytosine (5hmC) on the frequency of mutations in cancer and normal tissues. They show that 5hmC is associated with decreased mutations; the opposite effect to the better-studied epigenetic modification 5-methylcytosine.
\n \n\n\n \n 29 April 2016\n \n
\n\n \n\n \n\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nA panel discussion to promote the aspirations of Black and Minority Ethnic (BME) staff at the University of Oxford.
\n \n\n\n \n 22 April 2016\n \n
\n\n \n\n \n\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nWhat is the key to success for women who work in science? A new website, launched this week, delves into the experiences of successful women in science at the University of Oxford, through a collection of video narratives.
\n \n\n\n \n 7 April 2016\n \n
\n\n \n\n \n\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nThe NIHR Oxford Biomedical Research Centre will hold a public open day \u201cCelebrating Biomedical Research in Oxford\u201d Thursday April 21 from midday to 5pm at the John Radcliffe Hospital.
\n \n\n\n \n 24 March 2016\n \n
\n\n \n \n \n\n \n \n \nIn an Analysis article published in Nature Reviews Cancer, Gareth Bond and colleagues have shown that that commonly inherited single nucleotide polymorphisms (SNPs) occurring in genes of the p53 pathway affect the incidence of a broad range of cancers, more so than such genetic variants in other pathways. Mutations in p53 pathway genes are commonly found in many types of cancer, and these findings highlight that common inherited genetic
\n \n\n\n \n 18 March 2016\n \n
\n\n \n \n \n\n \n \n \nMads Gyrd-Hansen\u2019s group have published a new paper in Cell Reports that provides new molecular insights into the way a specific type of protein modification, called ubiquitin, is regulated.
\n \n\n\n \n 20 January 2016\n \n
\n\n \n \n \n\n \n \n \nDr John Christianson's research focusses on ER-associated degradation, which is responsible for clearing non-functional and orphan translation products. These processes play a central role in inherited diseases such a cystic fibrosis and various forms of cancer. Dr Christianson's long term goal is to identify novel points of interventions for cancer therapies.
\n \n\n\n \n 6 January 2016\n \n
\n\n \n\n \n\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nListen to Ludwig scientist Skirmantas Kriaucionis discussing his research on epigenetics and cancer. Epigenetic modifications such as methylations alter which sets of genes are expressed in specific cells and how this specificity is inherited across cell divisions. Cancer cells show particular epigenetic abnormalities which can be targeted for cancer therapies. More podcasts are available here
\n \n\n\n \n 17 December 2015\n \n
\n\n \n\n \n\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nEngaging the public with research helps empower people, broadens attitudes to academic research, and ensures that the work we do is relevant to society and its wider social concerns. Establishing a dialogue between researchers and the public means that society can benefit more fully from research outputs.
\n \n\n\n \n 24 November 2015\n \n
\n\n \n \n \n\n \n \n \nA post-doctoral fellow from Gareth Bond\u2019s group - Giovanni Stracquadanio - has been selected to receive a highly-competitive Keystone Symposia Future of Science Fund scholarship to support his attendance at a meeting on Genomics and Personalized Medicine in Banff, Canada.
\n \n\n\n \n 21 August 2015\n \n
\n\n \n \n \n\n \n \n \nLudwig scientist Colin Goding has been awarded a \u00a394,000 grant by the Masonic Samaritan Fund, to support a project searching for drugs that could be used in the future treat both cancer and neurodegenerative diseases. The donation was presented to Prof. Goding by James Hilditch, Provincial Grand Master for the Masonic Province of Oxfordshire, at the Old Road Campus Research Building on 15th October 2015.
\n \n\n\n \n 24 July 2015\n \n
\n\n \n \n \n\n \n \n \nIn studying how cells recycle the building blocks of DNA, Skirmantas Kriaucionis and colleagues have discovered a potential therapeutic strategy for cancer.
\n \n\n\n \n 24 July 2015\n \n
\n\n \n \n \n\n \n \n \nOn Saturday 19th September 2015, a team of nine researchers from Ludwig Oxford swapped labcoats for Lycra and took on the challenge of cycling 150km from Oxford to Cambridge.
\n \n\n\n \n 22 July 2015\n \n
\n\n \n \n \n\n \n \n \nDonem Avci, a postdoctoral researcher in John Christianson\u2019s group in Ludwig Oxford has been awarded an EMBO Long-term Fellowship for her work on the endoplasmic reticulum quality control machinery.
\n \n\n